CancerX
CancerX/cancerx.health

Applications are Open for the 2026 CancerX Accelerator Cohort

CancerX shared a post on LinkedIn:

“Applications are now open for the 2026 CancerX Accelerator Cohort!

This 5-month Accelerator program (Feb–Jun 2026) has been honed with 2 years of strong track record and demonstrated success in scaling oncology startups.

Are you ready to roll up your sleeves and collaborate with leading oncology champions, including Memorial Sloan Kettering Cancer Center, Johnson and Johnson, Moffitt Cancer Center, AstraZeneca, Elevance Health, Advocate Health, Rush University System for Health, Novartis US and more, to impact the following core areas?

  1. Reimagining clinical trials
  2. Care excellence in communities
  3. Smart care decisions and operations
  4. Reducing financial toxicity

We invite you to apply here on Constellation:

Deadline: October 28, 2025

Let’s accelerate the future of oncology innovation together.”

Applications are Open for the 2026 CancerX Accelerator Cohort

More posts featuring CancerX.